Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19731-5. doi: 10.1073/pnas.1014140107. Epub 2010 Nov 1.
Streptomyces clavuligerus, an industrially important producer of clavulanate as well as cephem antibiotics, also produces the N-acylated dithiolopyrrolone antibiotic holomycin, a reported inhibitor of RNA synthesis. The genome sequence of S. clavuligerus ATCC 27064 was examined for a potential biosynthetic gene cluster, assuming that holomycin arises from some derivative of an L-Cys-L-Cys dipeptide that has undergone eight-electron oxidation, fused five-five ring formation, and decarboxylation. ORFs 3483-3492 comprise a candidate cluster, with a predicted acyltransferase, a stand-alone nonribosomal peptide synthetase (NRPS) module, and four flavin-dependent oxidoreductases. Deletions of ORF3488, the NRPS module, and ORF3489, a phosphopantothenoylcysteine decarboxylase homolog, abolished holomycin production both in wild type and in a holomycin-overproducing mutant. Heterologous expression and purification of ORF3488 allowed demonstration of L-Cys-AMP formation and subsequent covalent tethering of Cys to the phosphopantetheinyl arm of the thiolation domain of this NRPS protein. Purified ORF3483 shows acyltransferase activity, converting holothin to holomycin and longer acylated homologs as the last step in antibiotic assembly.
产克拉维酸链霉菌(Streptomyces clavuligerus)是一种重要的工业生产菌,能够产生克拉维酸和头孢菌素类抗生素,同时还产生 N-酰化二硫吡咯酮类抗生素霍洛霉素。该抗生素是一种 RNA 合成抑制剂。我们对产克拉维酸链霉菌 ATCC 27064 的基因组序列进行了研究,寻找潜在的生物合成基因簇,假设霍洛霉素来源于 L-Cys-L-Cys 二肽的某种衍生物,该衍生物经历了八电子氧化、五碳五碳环形成和脱羧反应。ORF3483-3492 包含一个候选基因簇,其中包含一个预测的酰基转移酶、一个独立的非核糖体肽合成酶(NRPS)模块和四个黄素依赖型氧化还原酶。ORF3488、NRPS 模块和 ORF3489(磷酸泛酰巯基乙胺脱羧酶的同源物)的缺失均导致野生型和霍洛霉素高产突变株中霍洛霉素的生物合成被完全阻断。ORF3488 的异源表达和纯化使我们能够证明 L-Cys-AMP 的形成以及随后 Cys 与该 NRPS 蛋白硫醇结构域的磷酸泛酰巯基乙胺臂之间的共价连接。纯化的 ORF3483 显示出酰基转移酶的活性,能够将霍洛丁转化为霍洛霉素和更长的酰化同系物,这是抗生素装配的最后一步。